Skip to content

Link Between Rheumatoid Arthritis & Lung Disease

Search Clinical Trials

Trial Objectives

The purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease

Who Can Participate

Individuals with rheumatoid arthritis (RA), interstitial lung disease (ILD) or lung fibrosis may be eligible to participate.

Age: 18+ Gender: Any

Estimated Time Commitment

6 in-person visits, performed every year over 4 years

Payment & Reimbursement

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Faduma Ahmed

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors


Principal Investigators

Joshua J. Solomon

Joshua J. Solomon, MD


Michael P. Mohning

Michael P. Mohning, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required